Kips Bay Medical, Inc.  

(Public, NASDAQ:KIPS)   Watch this stock  
Find more results for kips
0.651
-0.009 (-1.33%)
Apr 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.65 - 0.68
52 week 0.57 - 1.48
Open 0.68
Vol / Avg. 0.00/289,674.00
Mkt cap 21.50M
P/E     -
Div/yield     -
EPS -0.23
Shares 33.01M
Beta 2.84
Inst. own 3%
May 20, 2014
Kips Bay Medical, Inc. Annual Shareholder Meeting - 4:30PM EDT - Add to calendar
Mar 12, 2014
Q4 2013 Kips Bay Medical, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin -3741.46% -4661.54%
Operating margin -3751.22% -4673.85%
EBITD margin - -4631.54%
Return on average assets -88.21% -66.72%
Return on average equity -93.92% -71.62%
Employees 14 -
CDP Score - -

Address

Suite 200, 3405 ANNAPOLIS LANE
MINNEAPOLIS, MN 55447
United States - Map
+1-763-2353540 (Phone)
+1-763-2353545 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Kips Bay Medical, Inc. is a medical device company focused on developing, manufacturing and commercializing its external saphenous vein support technology (eSVS MESH) for use in coronary artery bypass grafting (CABG) surgery. The Company�s eSVS MESH is a nitinol mesh sleeve that, when placed over a saphenous vein graft during CABG surgery, is designed to improve the structural characteristics and performance of the vein graft. The eSVS MESH is a kink-resistant extravascular tubular prosthesis made of knitted nickel/titanium, or nitinol, wire mesh.

Officers and directors

Manuel A. Villafana Chairman of the Board, Chief Executive Officer
Age: 73
Bio & Compensation  - Reuters
Scott Kellen Chief Financial Officer, Chief Operating Officer, Vice President - Finance, Secretary
Age: 47
Bio & Compensation  - Reuters
Randall Keith LaBounty Vice President - Regulatory and Clinical Affairs
Age: 50
Bio & Compensation  - Reuters
Robert E. Munzenrider CPA Lead Independent Director
Age: 68
Bio & Compensation  - Reuters
Robert J. Sheehy Independent Director
Age: 55
Bio & Compensation  - Reuters
Archie C. Smith Independent Director
Age: 54
Bio & Compensation  - Reuters